MedTrace Logo

Effects of Kinesio Taping in Patellofemoral Pain

NCT02827084 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2016-07-18

No results posted yet for this study

Summary

The study aims to analyze the immediate effects and 72 hours after application of the Kinesio Taping (KT) in the electromyographic activity of the vastus medialis oblique (VMO) and vastus lateralis (VL), the isokinetic performance of the quadriceps and referred pain of subjects with PFPS. The volunteers will be randomly assigned to one of the three groups and perform one of the protocols: control - remain at rest; KT - application of Kinesio Taping with tension in the VMO region; placebo - application of Kinesio Taping without tension, in the same region. All volunteers will be submitted to the evaluation of pain intensity, the electromyographic activity of the VMO and VL and dynamometric parameters in 3 times: before the application of KT, immediately after the application of KT and after 72h of application. Average effect estimates (differences between groups) for all variables will be calculated using the mixed model ANOVA with a significance level of 5% (p ≤ 0.05).

Conditions

  • Patellofemoral Pain Syndrome

Interventions

DEVICE

Kinesio Taping

Application of the Kinesio Taping with tension in the vatus mediallis muscle.

DEVICE

Placebo

Application of the Kinesio Taping without tension in the vatus mediallis muscle.

Sponsors & Collaborators

  • Universidade Federal do Rio Grande do Norte

    lead OTHER

Principal Investigators

  • Jamilson S Brasileiro, PhD · Universidade Federal do Rio Grande do Norte

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02827084 on ClinicalTrials.gov